Biotechnology Companies Worldwide
Location
Category
List of Biotechnology companies in All locations
796 companies
Sort by
We are focused on creating transformative therapies for patients suffering from a range of debilitating diseases, including sickle cell disease (SCD), renal diseases, cardiometabolic diseases, and neurodegenerative diseases. Our research and development efforts are centered around oral medications, offering a more accessible treatment option for patients globally.
IMMvention Therapeutix is a venture-funded company dedicated to advancing innovative treatments and improving patient outcomes. We leverage cutting-edge research in molecular biology to address unmet medical needs and bring impactful therapies to market. Our team combines deep scientific expertise with a commitment to patient-centric drug development.
Founded in 2017 and currently employing 13 individuals, IMMvention Therapeutix is rapidly progressing its pipeline of potential therapies, demonstrating significant promise in addressing complex diseases.
Our FDA-cleared system simplifies and standardizes fat transfer procedures, offering a consistent and affordable alternative to traditional fillers. We’re dedicated to advancing innovative solutions for aesthetics, wound care, and future medical applications, including orthopedic and gastrointestinal surgery.
Syntr’s automated process dramatically improves fat cell viability and repeatability, leading to superior patient outcomes and a streamlined workflow for practitioners. We are currently enrolling patients in a randomized control trial to investigate using autologous microsized fat tissue in the healing of diabetic foot ulcers.
Join our growing network of clinician partners and unlock the potential of microfat.
We partner with biopharma, nonprofit, and regulatory stakeholders to understand disease impacts, unmet needs, and patient preferences. Our approach centers on providing tailored solutions, including early-stage patient advocacy, regulatory and legislative support, access and reimbursement planning, and patient experience data collection.
Founded in 2022 by Jenn McNary, Richie Kahn, and Jen Shumsky, Canary Advisors combines decades of experience in rare disease clinical development, patient advocacy, and regulatory affairs. We’re committed to translating research into actionable insights that truly benefit patients and their families. We’ve been recognized for our responsiveness, impact, and innovative strategies, consistently prioritizing the patient voice in drug and device development.
Our team provides a range of services, from clinical trial concierge to patient-focused drug development consultancy, ensuring that every project is strategically aligned with corporate objectives and patient needs.
We provide a comprehensive selection of fittings, connectors, tubing, and flow control equipment, ensuring researchers and engineers have the essential components for their experiments and manufacturing processes. Our commitment to rapid order fulfillment from our Irvine facility allows you to focus on innovation, while our diverse product range caters to a wide spectrum of applications.
ELEXAN Scientific is your trusted partner for reliable, high-quality microfluidic solutions, supporting advancements across biotechnology research and beyond. We strive to streamline your sourcing experience, empowering you to push the boundaries of discovery.
Our initial product, a patent-pending tissue-engineered nipple-areolar complex (NAC), provides surgeons with an off-the-shelf, acellular graft. This NAC acts as a building frame, stimulating the patient’s own tissue regeneration to create a natural-looking nipple and areola.
BioAesthetics is currently in the pre-clinical phase, dedicated to advancing this groundbreaking technology and offering a significant advancement in reconstructive surgery. We are committed to providing healthcare providers with a reliable and effective solution for breast cancer patients.
We serve plastic and reconstructive surgeons seeking enhanced options for their patients, addressing a critical need in the field of breast reconstruction.
We are pioneering the development of innovative topical ocular biologic solutions, specifically dHGF, to address unmet needs in ophthalmology, particularly in conditions like Limbal Stem Cell Deficiency (LCSD) and neurotrophic keratopathy (NK).
Founded on the groundbreaking research of Dr. Reza Dana and Dr. Sunil Chauhan at the Massachusetts Eye and Ear Infirmary, Claris Bio combines scientific expertise with a seasoned leadership team – including Clarke Atwell, Susan Orr, Henry Rath, and Tomi Luan – to accelerate the translation of promising therapies into life-changing treatments. Our commitment to data-driven decision making and robust preclinical findings positions us at the forefront of corneal therapy.
We are not currently hiring.
We specialize in developing and delivering innovative biological solutions for growers seeking to improve crop yield, quality, and overall profitability. Bontera’s approach centers on harnessing the power of naturally-occurring soil microbes – including Bacillus, Trichodermas, and Rhizobium – to create robust root development, increased nutrient availability, and enhanced plant health.
Our custom blend solutions and market-ready products are 100% organically derived, compatible with sustainable and organic growing practices, and represent a commitment to nurturing land health for future generations. We work with growers to tailor microbial blends to specific crop and soil needs, supporting a more resilient and productive agricultural ecosystem.
We support companies and organizations across the agricultural biotechnology sector, including seed producers, technology providers, and biotech associations, by offering comprehensive programs focused on transgene technology management, genome editing stewardship, and broader plant breeding innovation.
Our approach centers on flexibility, adaptability, and accessibility, ensuring that our programs integrate seamlessly into existing systems and provide valuable guidance to organizations of all sizes. We help ensure quality products reach the market, fostering trust with growers and consumers through robust stewardship practices.
Founded in 2008 as Excellence Through Stewardship, we’ve grown to encompass the Global Stewardship Group, reflecting our expanded scope of services and commitment to a more sustainable and responsible biotechnology landscape.
We are harnessing the power of advanced microbiome genomics and data science to develop innovative preventative and precision treatment strategies. Our proprietary Resilient Analytics platform combines high-resolution genomic analyses, machine learning algorithms, and targeted in vitro assays to identify naturally occurring microbiome-derived strains with immune activation and pathogen inhibition properties.
Resilient Biotics is dedicated to reducing reliance on antibiotics and improving patient outcomes through the targeted modulation of the respiratory microbiome. We are focused on creating a new class of therapeutics that leverages the inherent resilience of the microbiome to combat complex infectious diseases.
Founded in 2017, Resilient Biotics has secured significant venture funding and established strategic partnerships to accelerate the development of its pipeline. Our team, led by Rachelle Galvin and Christopher Belnap, brings together decades of experience in scientific innovation and drug development.
We help early-stage biotech, pharmaceutical, and GxP service provider organizations build and maintain quality systems that are appropriately scaled to their needs and stage of development. Our focus is on providing flexible, senior-level quality expertise without the expense of a full-time head of quality.
At B3 Quality, we understand that many companies, particularly those in their early stages, don’t require a full-time quality leader. Instead, they need strategic quality leadership that can plan, direct, and conduct quality activities tailored to their specific phase. We offer fractional quality leadership, QMS builds, and GxP consulting to ensure you’re compliant and focused on innovation.
Our approach, Right-Sized Quality™, ensures you get the expertise you need when you need it, so you can stay compliant and focused on innovation. We’ve helped organizations like Blake’s and Mike’s companies build robust quality systems, and we’re committed to helping you do the same.
We provide a revolutionary solution for drug discovery, enabling scientists to accelerate their research and development processes. Our platform utilizes artificial intelligence to streamline complex molecular simulations, dramatically reducing the time and resources required for traditional CADD (Computer-Aided Drug Design).
QuantaBricks offers a free AI transformation evaluation for drug discovery teams, demonstrating the potential of our technology. We are committed to democratizing access to advanced molecular modeling, fostering innovation and driving breakthroughs across the biotechnology and pharmaceutical industries.
With a team of experienced scientists and engineers, QuantaBricks is dedicated to pushing the boundaries of what’s possible in molecular discovery, helping researchers unlock new treatments and therapies.
We specialize in supplying researchers with ethically sourced, non-transplantable human organs and tissues, obtained through a unique network of partnerships with 31 of the 55 CMS-regulated Organ Procurement Organizations (OPOs). This allows us to offer unparalleled access to both healthy and diseased samples, including internal organs, skin, cerebrospinal fluid (CSF), synovial fluid, and processed or snap-frozen tissues.
Novabiosis transforms complex biological material into ready-to-use research solutions, utilizing our expert cell isolation team to produce high-viability primary cells – cryopreserved and rigorously quality-controlled to ensure reproducible, early-stage research. Our services support advancements in cell biology, hepatocyte research, and more.
Founded in 2021 and currently employing 8 staff, Novabiosis is dedicated to expanding the precious gift of organ donation by minimizing discard and accelerating scientific discovery.
Our flagship initiative, Pattern.org, empowers patients to advocate for their care and directly impact cancer research, providing personalized data and treatment options.
Rare Cancer Research Foundation distinguishes itself by focusing on patient-centric research, building the tools and infrastructure to enable patients to drive research and researchers to advance treatment development. We are committed to transforming the landscape of rare cancer care through innovation and collaboration. Pattern.org and the Genomic Sequencing program are key components of our mission.
We provide comprehensive solutions for identifying and quantifying constituents and contaminants in substances and raw materials, supporting critical stages of product development and regulatory compliance.
Mass Spec Lab distinguishes itself through its commitment to utilizing state-of-the-art instrumentation and expert methodologies, ensuring timely, accurate, and targeted data for our clients. We offer a range of services including Leachables & Extractables testing, Targeted Screening Analysis, Structural Elucidation, Fingerprinting & Equivalence Testing, and Stability Testing.
Founded in 2014, Mass Spec Lab is a division of InVision Biomedical Group, dedicated to providing custom analytical services to the ophthalmic biomedical device sector and beyond.
We are dedicated to addressing a significant unmet need in the treatment of COPD and asthma, where mucus plugs frequently block airways, leading to reduced lung function and diminished quality of life.
AER-01, our lead therapeutic candidate, represents a novel approach – the first therapy designed to liquify mucus plugs by cleaving the chemical bonds that thicken mucus, effectively opening airways and restoring airflow.
Developed from groundbreaking research at UCSF, UCD, and Trinity College Dublin, and supported by over $18M in NIH grant funding, Aer Therapeutics is committed to transforming respiratory care and empowering patients to breathe freely. AER-01 is the first inhaled therapy developed to clear mucus blockages, helping to break the cycle of inflammation and restore the freedom to breathe.
We transform crop protection with rapid development of new products based on innovative, novel peptides and RNAi that are tailor-made to the needs of farmers. Our core technology, EvoStat, enables the evolution of these products to combat potential pest or pathogen resistance, offering a long-term and cost-effective solution for farmers.
Backed by a team of experienced scientists and significant venture capital funding, Innatrix is committed to empowering farmers to increase yields by at least 10% while achieving a return on investment exceeding 3x. We are focused on providing robust, sustainable solutions to the challenges of crop protection.
Currently, we are developing InnaLB™ for potato late blight, InnaNema™ for soybean cyst nematode, and InnaHLB™ for citrus greening.
We’re building on the pioneering tissue regeneration research of Dr. Farshid Guilak, Dr. Bradley Estes, and Dr. Frank Moutos, leveraging their groundbreaking work to develop innovative implant solutions.
CytexOrtho’s approach focuses on regrowing cartilage and repairing damaged joints, offering a potential alternative to traditional hip replacements and addressing the growing market for osteoarthritis treatment. Our commitment to advancing patient care drives our research and development efforts, aiming to provide effective and lasting solutions for individuals suffering from joint pain.
Currently, our products are in development and not yet approved by the FDA or commercially available. We are focused on bringing this transformative technology to market, contingent upon regulatory approval.
We provide science-backed solutions to help families understand and manage infant food reactivity, offering a trusted alternative to blind elimination diets or relying solely on formula.
Free to Feed™ combines rigorous research with compassionate support, empowering parents with personalized plans and expert guidance. Our innovative allergen detection system, developed by a team of experienced scientists and healthcare professionals, provides valuable insights into breast milk composition, helping mothers make informed feeding decisions.
Founded in 2018 by Dr. Trill Paullin, PhD, Free to Feed™ is committed to advancing maternal-infant health through evidence-based innovation and a dedication to improving the lives of families facing these challenges.
We leverage our proprietary IVS™ and IVE™ discovery platforms to pioneer a new category of Synergistic Synbiotics™ – carefully selected combinations of probiotics and prebiotics designed to fundamentally change the gut microbiome.
Synbiotic Health distinguishes itself through a deep understanding of the ecological framework within the gut, focusing on establishing and competing beneficial bacteria. Our science prioritizes documented health benefits, offering a superior approach to existing probiotic offerings. Founded in 2018, we’ve grown to a team of 13 dedicated scientists and experts, committed to improving human health through innovative microbiome solutions.
We are dedicated to advancing the science of gut health and delivering impactful, evidence-based products to consumers and healthcare professionals alike.
Following the merger with Idera Pharmaceuticals in 2022, Aceragen is dedicated to advancing its pipeline of novel treatments, particularly in the area of rare genetic diseases. We leverage a patient-centric approach, combining scientific expertise with a deep understanding of the challenges faced by patients and their families.
Aceragen’s core expertise lies in the development of targeted therapies, utilizing innovative technologies to address unmet medical needs. We are committed to improving the lives of patients and their families through the discovery and delivery of transformative medicines. Our team combines decades of experience in drug development, manufacturing, and commercialization, ensuring a robust pathway to market for our promising therapies. We operate with a strong focus on ethical practices and patient well-being.
We leverage the power of quantum computing to revolutionize drug discovery, compressing the lead time for pre-clinical drug candidates from five years to just four months. This allows us to generate up to 100 drug blueprints annually, enabling rapid adaptation within the precision medicine market.
PolarisQB’s unique approach utilizes Quantum Annealing and Quantum Inspired Algorithms to explore a chemical space far exceeding the capabilities of traditional methods – over 10^30 chemical spaces compared to the limitations of conventional screening. We are dedicated to accelerating the development of novel therapeutics and personalized medicine solutions.
Founded in 2020, PolarisQB is rapidly establishing itself as a leader in computational chemistry, with a team of experts and a growing portfolio of intellectual property. We collaborate with pharmaceutical, biotech, and agricultural companies to unlock the potential of quantum computing for drug design.
We are dedicated to improving global access to life-saving epinephrine treatments, particularly in underserved regions where traditional auto-injectors are unavailable or unreliable.
Our flagship product, Nasdepi®, represents a significant advancement in allergy care, offering a needle-free, heat-stable, and user-friendly alternative to existing epinephrine delivery methods. Nasdepi® is engineered for rapid absorption, simple administration, and long shelf life, addressing critical barriers to effective treatment.
Belhaven Biopharma’s mission is to empower individuals and families facing severe allergies with a reliable, accessible, and pain-free solution, ultimately reducing the risk of life-threatening anaphylaxis events worldwide.
Spark’s mission is to develop and implement artificial intelligence algorithms for medical imaging, fostering collaboration between physicians and machine learning experts across various Duke departments, including Radiology, Surgery, Orthopaedic Surgery, and Computer Science.
This interdisciplinary initiative leverages significant investments from the Departments of Radiology and Surgery to drive cutting-edge research into surgical applications of imaging AI, ensuring the development of safe, effective, ethical, and equitable AI tools for healthcare.
Spark builds upon existing collaborative work across Duke, expanding its network of collaborators to address the widespread presence of medical imaging in nearly all medical specialties.
Founded in 2016 by leading researchers from Duke University Medical Center, Darell Bigner, MD, and Matthias Gromeier, MD, Istari Oncology is focused on harnessing the power of the immune system to combat these challenging diseases.
Our core expertise lies in developing novel immuno-oncology and immunotherapy platforms, utilizing virology, immunology, and monoclonal development to create targeted therapies. We are dedicated to advancing clinical-stage research and ultimately delivering life-changing treatments to patients battling cancer.
Istari Oncology is committed to pushing the boundaries of cancer treatment through rigorous scientific investigation and a patient-centric approach.
We support a diverse ecosystem of companies, from startups to multinational corporations, fostering innovation and collaboration across the sector.
NCLifeSci delivers critical policy and advocacy leadership, drives workforce development programs, and provides invaluable industry connections, enabling our members to thrive in a global marketplace. We champion policies that encourage growth and support a strong life sciences workforce, ultimately contributing to economic opportunity and improved quality of life.
As the leading voice for North Carolina’s life sciences, we are committed to building a vibrant and successful industry for years to come.
We specialize in the diagnosis, treatment, and preventative care of pets, including dogs, cats, and other small animals. Our experienced team of veterinarians and technicians are dedicated to ensuring the health and well-being of your beloved companions.
From routine check-ups and vaccinations to advanced surgical procedures and emergency care, we offer a full range of services to meet your pet’s every need. We are committed to delivering compassionate, personalized care in a comfortable and welcoming environment. We focus on building long-term relationships with our clients and their furry, feathered, and scaled family members.
Our services include pet wellness exams, dental care, surgery, emergency services, and laboratory diagnostics. We strive to be your trusted partner in your pet’s healthcare journey.
We empower individuals and healthcare providers to make more informed decisions about their health through accessible and affordable precision medicine solutions. Our TargetRichTM enrichment technology and next-generation sequencing capabilities provide comprehensive genetic insights.
Kailos Genetics combines robust next generation sequencing with illuminating, high-powered analytics to produce accurate and comprehensive genetic information. We offer a complete sequencing solution, from assay design to data analysis, and integrate seamlessly into existing laboratory workflows.
Founded in 2010, Kailos Genetics is committed to advancing precision medicine and improving patient outcomes.
We are pioneering a revolutionary approach to cardiovascular health, targeting the genetic drivers of vascular decline with precision RNA medicines. Our core technology, including Target-Site Blockers (TSBs) and Antisense Oligonucleotides (ASOs), aims to restore vascular health and extend cardiovascular healthspan.
Cardivia Labs’ proprietary miRNA-targeting strategy and cell-specific vascular targeting offer a unique advantage in developing therapies for conditions like atherosclerosis and vascular aging. Our team, led by scientist-founder Ismail Cimen, is dedicated to translating cell-targeted RNA therapeutics into impactful treatments.
Currently, we are advancing programs targeting CXCR4, SIRT6, and TET2, with an IND-enabling study planned for CXCR4-TSB. We are committed to transforming outcomes for millions at risk of heart attack and stroke.
We are focused on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor, a protein implicated in a broad range of disease states including cancer metastasis and certain immunological conditions.
Leronlimab’s unique competitive inhibition of the CCR5 receptor offers a paradigm-shifting therapeutic approach, differentiating it from other CCR5 antagonists.
CytoDyn’s commitment is to enhancing the lives of patients through targeted medicine, leveraging the potential of leronlimab across multiple disease areas.
Diversified Scientific Inc is a leading biotechnology company based in Birmingham, Alabama, specializing in innovative IT solutions and managed services. We empower businesses across Commercial, Federal, and SLED sectors with comprehensive technology infrastructure, including collaboration, data center, and cybersecurity solutions. Our approach focuses on simplifying complex IT environments and unifying security measures to protect critical assets. Founded in 1991, DSI Tech has grown to become a national IT Value-Add Reseller (VAR) and Service Provider, recognized as a Certified Minority-Owned Small Business. We are committed to delivering secure, innovative, and cost-effective IT solutions with a primary focus on customer service and creating a valuable experience.
We provide complete tech solutions that cover the entire IT infrastructure including Collaboration, Data Center, Hybrid Work, Internet of Things, Networks, Security, and Wireless. Our expertise extends to designing and implementing robust cybersecurity strategies, combining Cisco’s security products with our managed security services. We also offer nationwide contracts for a variety of customers including Federal agencies, local & state governments, and K-12 & higher education institutions.
DSI Tech is proud to be a Cisco Gold Partner, holding multiple specializations including Cloud & Data Center, Collaboration, Networking, Security, and Services. We are also a HPE Aruba Gold Partner and HPE Silver Partner for Hybrid IT, and a Palo Alto Networks NextWave Innovator. Our leadership team, led by CEO Atul Bhatia and President Vinu Luthra, is dedicated to driving innovation and delivering exceptional value to our clients.
Eurofins DiscoverX is a leading provider of innovative cell-based assays and services for drug discovery and development, based in Fremont, California. We empower scientists with trusted solutions to accelerate research and drug discovery programs with confidence. Our comprehensive portfolio includes recombinant GPCR proteins, active cell lines, and ready-to-use assays, supporting applications from initial screening to QC lot release. As the products company of Eurofins Discovery, we’re part of the Eurofins BioPharma global network, contributing to the discovery and development of life-saving therapeutics. We develop and manufacture cutting edge assays, stable cell lines, ready-to-use kits (including bioassays), membrane preps, enzymes, and reagents for small molecule and biologic immuno-oncology, cytotoxicity, compound-target engagement, potency and QC lot release, pharmacotrafficking, and many other applications.
Eurofins DiscoverX serves a global community of researchers and pharmaceutical companies, providing the tools and expertise needed to navigate complex drug discovery challenges. We specialize in supporting a wide range of target families, including GPCRs, kinases, epigenetics, and ion channels. Our commitment to quality and innovation ensures reliable and reproducible results, accelerating the path to new therapies.
What sets Eurofins DiscoverX apart is our integrated approach, combining cutting-edge technology with deep scientific expertise. We offer custom assay development services, alongside our extensive catalog of validated products. Founded in 2000, we’ve built a strong reputation for delivering exceptional value and supporting breakthrough discoveries. With 118 employees across three centers of excellence – Fremont, St. Louis, and Poitiers – we’re dedicated to advancing the future of medicine.
Immunowake, Inc. is a biotechnology company based in Birmingham, Alabama, specializing in cancer drug discovery. We are dedicated to developing safe and effective cytokine immune modulators, aiming to overcome tumor immune suppression and reactivate the patient’s own immune system to identify and eliminate cancer cells. Our approach, reflected in our name ‘Immunowake,’ focuses on ‘awakening’ the immune system to offer renewed hope. We leverage a robust research platform and a strong research pipeline to treat both cancer and autoimmune diseases.
Our core technology centers on precisely delivering cytokines to maximize their anti-tumor potential while minimizing systemic toxicity. This innovative strategy utilizes cytokines – key players in coordinating immune cell activation – to effectively combat cancer.
Immunowake is building a powerful pipeline of immune cytokine therapies, and recently secured investment from Haiju Talent Investment Fund, further solidifying our position at the forefront of cancer immunotherapy.
Nectero Therapeutics is a clinical-stage biotech company based in Tempe, Arizona, dedicated to transforming the treatment of aneurysmal disease. We are pioneering novel therapies, specifically the Nectero EAST ® System, to stabilize growth and prevent rupture of small to mid-sized abdominal aortic aneurysms (AAA). Our approach utilizes an endovascular technique to deliver a proprietary mixture, minimizing the need for major intervention like EVAR or open surgery. Led by a highly accomplished, multidisciplinary management team and supported by renowned physician leaders, Nectero Therapeutics is committed to improving patient outcomes and extending lives.
The Nectero EAST ® System offers a promising alternative for patients with AAAs that may not otherwise qualify for traditional treatment options. By strengthening the aortic tissue around the aneurysm, we aim to significantly delay or prevent the need for invasive procedures. We are focused on developing innovative solutions to address a significant public health concern.
Nectero Medical, Inc. (DBA Nectero Therapeutics) is at the forefront of this research, driven by a passion for advancing vascular medicine and providing hope for patients and their families. We are dedicated to rigorous clinical development and regulatory compliance, ensuring the safety and efficacy of our therapies.
FasTrain Courses is a Vancouver-based training provider specializing in comprehensive professional development for the bio/pharmaceutical and biotech industries. We deliver interactive online courses designed to meet stringent FDA, EMA, and other regulatory agency training requirements. Our experienced instructors, practicing professionals, offer practical knowledge and solutions to help companies in the global market. We focus on solving technical and regulatory challenges, providing a competitive edge for small, medium, and large organizations involved in product development.
FasTrain Courses offers a wide range of courses, including CMC, sourcing biological raw materials, forced degradation, stability testing, and statistical methods. Our commitment is to provide flexible, accessible training that saves time and reduces travel costs.
Our key differentiators include our experienced instructors, stand-alone session format, and readily available recordings, ensuring flexibility for busy professionals. We also offer a comprehensive certification program and ongoing updates on cGXP regulations.
Company Name | Location | Category | Employees | Accuracy | Website | |
|---|---|---|---|---|---|---|
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@immventionthera.com | http://www.immventionthera.com | ||
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@syntrhealth.com | http://www.syntrhealth.com | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@canaryadvisorsllc.com | http://www.canaryadvisorsllc.com | ||
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@elexansci.com | http://elexansci.com | ||
Research Triangle Park, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | contact@bio-aesthetics.com | http://www.bio-aesthetics.com | ||
Jersey City, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@clarisbio.com | https://clarisbio.com/ | ||
Dallas, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@bontera.com | http://www.bontera.com | ||
Washington, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@excellencethroughstewardship.org | http://excellencethroughstewardship.org | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@resilientbiotics.com | http://www.resilientbiotics.com | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@b3quality.com | https://b3quality.com | ||
Newark, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@quantabricks.xyz | https://www.quantabricks.xyz/ | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | support@novabiosis.com | https://novabiosis.com/ | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@rarecancer.org | http://rarecancer.org | ||
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@massspeclab.com | http://www.massspeclab.com/ | ||
Research Triangle Park, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@aertherapeutics.com | http://aertherapeutics.com | ||
Research Triangle Park, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@innatrix.com | https://www.innatrix.com/ | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@cytexortho.com | https://cytexortho.com | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@freetofeed.com | http://www.freetofeed.com | ||
Lincoln, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | sales@synbiotichealth.com | http://synbiotichealth.com/ | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@aceragen.com | https://www.aceragen.com/ | ||
RTP, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | contact@polarisqb.com | http://www.polarisqb.com | ||
Research Triangle Park, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@belhavenbio.com | http://www.belhavenbio.com | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | aihealth@duke.edu | https://aihealth.duke.edu/spark/ | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@istarioncology.com | http://istarioncology.com | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@nclifesci.org | https://www.nclifesci.org/ | ||
Canyon Country, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@canyoncountryvet.com | http://www.canyoncountryvet.com | ||
Huntsville, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | info@kailosgenetics.com | http://www.KailosGenetics.com | ||
Rochester, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@cardivialab.com | http://www.cardivialab.com | ||
VANCOUVER, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 20-30 | info@cytodyn.com | https://www.cytodyn.com/ | ||
Birmingham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | sales@dsitech.com | http://www.dsitech.com | ||
Fremont, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 100-150 | info@discoverx.com | http://www.discoverx.com | ||
Birmingham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | info@immunowake.com | https://www.immunowake.com/ | ||
Tempe, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 30-50 | info@necterotx.com | http://www.necteromedical.com | ||
Vancouver, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@fastraincourses.com | https://fastraincourses.com/ | ||
Grand Rapids, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@movefactorx.com | http://www.movefactorx.com | ||
Ontario, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 50-100 | info@biomedservicesinc.com | http://www.biomedservicesinc.com | ||
Salt Lake City, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | sales@nanoshellcompany.com | http://www.nanoshellcompany.com | ||
Rochester, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | info@hajim.rochester.edu | https://www.hajim.rochester.edu/bme/graduate/mps-network.html | ||
Fremont, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | info@solutionsforbiotech.com | http://www.solutionsforbiotech.com/ | ||
Secunderabad, India | Health and Medical +1 Health and Medical, Science and Engineering | 200-500 | info@prathista.com | http://www.prathista.com | ||
Huntsville, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@skyangbio.com | http://www.skyangbio.com | ||
Worcester, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@vitathreads.us | http://www.vitathreads.us | ||
Ontario, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | sales@lyxia.com | http://www.lyxia.com | ||
New Haven, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@lithuanian-american.org | http://lithuanian-american.org/m/ | ||
Fremont, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 50-100 | info@anaspec.com | http://www.anaspec.com | ||
Fremont, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 10-20 | info@probius.bio | http://www.probius.bio | ||
Beaverton, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@joinisa.io | http://joinisa.io | ||
Fort Lauderdale, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@renegadebc.com | http://www.renegadebc.com | ||
Spokane, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@pilgrimpathways.com | http://pilgrimpathways.com | ||
Fremont, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | contact@dentalplacements.net | http://dentalplacements.net |
50/796 results
Frequently asked questions
Updated 23 October 2026
What is Enterprise League?
Enterprise League is a free business directory that helps buyers find the right company by sector and country. Every company has a profile showing what it does, what it offers and how to get in touch.
Is it free to list my company?
Yes, and it stays free: no card, no paid tier. Your profile appears in search results and category pages, can show up to 20 products and services, and lets buyers message you or ask for a quote.
How does verification work, and what does it cost?
Verifying your company is free. Confirm a code we email to an address at your company’s website, or send a company registration document for our team to check, and the verified badge appears on your profile. To show the badge in the directory and search results as well, take out a subscription: the first 14 days are free, and the price is on our pricing page.
Where does the company information come from?
Most profiles are built from public sources, such as official company registers. Claim your company’s profile to correct its details and add your own.
How do I claim or correct my company’s profile?
Open your company’s profile and choose Claim Profile. If you use an email address at your company’s website, a 6-digit code makes the profile yours at once; otherwise our team reviews your request, usually within a few days. Spotted a mistake on a company that isn’t yours? Tell us through our contact page.